Key Points
- J.H. Whitney Equity Partners V sold 919,389 shares of Aveanna Healthcare at an average price of $8.00, totaling about $7.36 million, trimming its stake by 6.84%.
- The same insider also sold 5.84 million shares on June 3 at an average price of $6.24, highlighting a broader pattern of recent share reduction.
- Aveanna Healthcare recently beat earnings expectations, reporting EPS of $0.18 versus $0.13 expected and revenue of $647.91 million, while analysts currently rate the stock a Moderate Buy with a consensus target price of $10.50.
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) major shareholder J.H. Whitney Equity Partners V sold 919,389 shares of the stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $8.00, for a total value of $7,355,112.00. Following the transaction, the insider owned 12,531,158 shares of the company's stock, valued at $100,249,264. The trade was a 6.84% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Large shareholders that own at least 10% of a company's stock are required to disclose their transactions with the SEC.
J.H. Whitney Equity Partners V also recently made the following trade(s):
- On Wednesday, June 3rd, J.H. Whitney Equity Partners V sold 5,842,240 shares of Aveanna Healthcare stock. The shares were sold at an average price of $6.24, for a total value of $36,455,577.60.
Aveanna Healthcare Price Performance
NASDAQ AVAH opened at $8.64 on Friday. The company has a market cap of $1.88 billion, a PE ratio of 7.32, a price-to-earnings-growth ratio of 0.88 and a beta of 1.93. Aveanna Healthcare Holdings Inc. has a 52 week low of $3.73 and a 52 week high of $10.32. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35. The firm's 50-day simple moving average is $7.14 and its two-hundred day simple moving average is $7.58.
Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last issued its earnings results on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, topping analysts' consensus estimates of $0.13 by $0.05. The firm had revenue of $647.91 million during the quarter, compared to analyst estimates of $613.22 million. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The company's quarterly revenue was up 15.9% compared to the same quarter last year. Research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.65 earnings per share for the current year.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on AVAH shares. BMO Capital Markets lowered their target price on shares of Aveanna Healthcare from $11.00 to $10.00 and set an "outperform" rating on the stock in a report on Friday, March 20th. Stephens upgraded Aveanna Healthcare from an "equal weight" rating to an "overweight" rating and boosted their price objective for the company from $10.00 to $11.00 in a research note on Friday, May 15th. Royal Bank Of Canada raised Aveanna Healthcare from a "sector perform" rating to an "outperform" rating and set a $10.00 price objective on the stock in a report on Wednesday, June 3rd. Barclays reduced their target price on Aveanna Healthcare from $9.50 to $9.00 and set an "overweight" rating for the company in a report on Monday, May 18th. Finally, Truist Financial increased their price target on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the stock a "hold" rating in a report on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $10.50.
Check Out Our Latest Research Report on Aveanna Healthcare
Hedge Funds Weigh In On Aveanna Healthcare
Several hedge funds and other institutional investors have recently added to or reduced their stakes in AVAH. Caitong International Asset Management Co. Ltd increased its stake in Aveanna Healthcare by 252.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company's stock worth $27,000 after acquiring an additional 2,400 shares during the last quarter. Summit Securities Group LLC bought a new stake in shares of Aveanna Healthcare during the 1st quarter valued at about $53,000. Quantbot Technologies LP purchased a new position in shares of Aveanna Healthcare during the second quarter worth about $43,000. EverSource Wealth Advisors LLC grew its holdings in shares of Aveanna Healthcare by 88,100.0% during the third quarter. EverSource Wealth Advisors LLC now owns 11,466 shares of the company's stock worth $102,000 after purchasing an additional 11,453 shares in the last quarter. Finally, Entropy Technologies LP bought a new position in shares of Aveanna Healthcare in the third quarter worth approximately $107,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.
Aveanna Healthcare Company Profile
(
Get Free Report)
Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna's offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.
In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
